| |
| |
|
| Insider
Information: |
Lindell Jody S |
| Relationship: |
Director |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
256,174 |
|
|
Indirect Shares
|
19,793 |
|
|
| Direct
Value |
$632,750 |
|
|
|
Indirect Value
|
$1,776,422 |
|
|
| Total
Shares |
275,967 |
|
|
| Total
Value |
$2,409,172 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
5
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -16.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cooper Companies Inc |
COO |
|
2020-04-01 |
0 |
2023-01-06 |
19,793 |
Premium* |
|
|
PDL Biopharma Inc |
PDLI |
Director |
2018-06-08 |
256,174 |
2009-06-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| COO |
Cooper Companies Inc |
|
– • – |
2023-01-06 |
4 |
OE |
$128.35 |
$128,350 |
I/I |
1,000 |
14,543 |
0 |
- |
|
| COO |
Cooper Companies Inc |
|
– • – |
2023-01-06 |
4 |
S |
$344.30 |
$344,304 |
I/I |
(1,000) |
13,543 |
0 |
% |
|
| COO |
Cooper Companies Inc |
|
– • – |
2022-04-04 |
4 |
S |
$421.04 |
$294,728 |
I/I |
(700) |
13,543 |
0 |
% |
|
| COO |
Cooper Companies Inc |
|
– • – |
2022-04-01 |
4 |
OE |
$0.00 |
$0 |
I/I |
700 |
14,243 |
0 |
- |
|
| COO |
Cooper Companies Inc |
|
– • – |
2021-07-02 |
4 |
S |
$405.54 |
$1,824,919 |
I/I |
(4,500) |
13,543 |
0 |
% |
|
| COO |
Cooper Companies Inc |
|
– • – |
2021-07-02 |
4 |
OE |
$98.45 |
$443,025 |
I/I |
4,500 |
18,043 |
0 |
- |
|
| COO |
Cooper Companies Inc |
|
– • – |
2020-09-16 |
4 |
OE |
$66.80 |
$434,200 |
I/I |
6,500 |
19,054 |
0 |
- |
|
| COO |
Cooper Companies Inc |
|
– • – |
2020-09-16 |
4 |
S |
$338.69 |
$2,201,453 |
I/I |
(6,500) |
12,554 |
0 |
% |
|
| COO |
Cooper Companies Inc |
|
– • – |
2020-04-01 |
4 |
D |
$273.05 |
$249,295 |
D/D |
(913) |
0 |
0 |
- |
|
| COO |
Cooper Companies Inc |
|
– • – |
2020-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
913 |
913 |
0 |
- |
|
| COO |
Cooper Companies Inc |
|
– • – |
2020-01-06 |
4 |
S |
$321.01 |
$1,123,534 |
I/I |
(3,500) |
12,554 |
0 |
% |
|
| COO |
Cooper Companies Inc |
|
– • – |
2020-01-06 |
4 |
OE |
$49.57 |
$173,495 |
I/I |
3,500 |
16,054 |
0 |
- |
|
| COO |
Cooper Companies Inc |
Director |
• • – |
2019-06-24 |
4 |
S |
$328.29 |
$984,857 |
I/I |
(3,000) |
12,554 |
0 |
- |
|
| COO |
Cooper Companies Inc |
Director |
• • – |
2019-06-24 |
4 |
OE |
$49.57 |
$148,710 |
I/I |
3,000 |
15,554 |
0 |
- |
|
| COO |
Cooper Companies Inc |
Director |
• • – |
2019-04-02 |
4 |
S |
$297.09 |
$129,828 |
I/I |
(437) |
12,554 |
0 |
- |
|
| COO |
Cooper Companies Inc |
Director |
• • – |
2019-04-01 |
4 |
OE |
$0.00 |
$0 |
I/I |
437 |
12,991 |
0 |
- |
|
| COO |
Cooper Companies Inc |
Director |
• • – |
2019-04-01 |
4 |
S |
$296.12 |
$871,948 |
I/I |
(2,943) |
0 |
0 |
- |
|
| COO |
Cooper Companies Inc |
Director |
• • – |
2019-03-08 |
4 |
OE |
$28.52 |
$213,900 |
I/I |
7,500 |
20,054 |
0 |
- |
|
| COO |
Cooper Companies Inc |
Director |
• • – |
2019-03-08 |
4 |
S |
$284.59 |
$2,134,425 |
I/I |
(7,500) |
12,554 |
0 |
- |
|
| COO |
Cooper Companies Inc |
Director |
• • – |
2019-01-09 |
4 |
GA |
$0.00 |
$0 |
I/I |
2,943 |
2,943 |
0 |
- |
|
| COO |
Cooper Companies Inc |
Director |
• • – |
2019-01-09 |
4 |
GD |
$0.00 |
$0 |
I/I |
2,943 |
0 |
0 |
- |
|
| COO |
Cooper Companies Inc |
Director |
• • – |
2018-11-15 |
4 |
OE |
$0.00 |
$0 |
I/I |
1,151 |
12,554 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2018-06-08 |
4 |
A |
$2.76 |
$150,000 |
D/D |
54,348 |
256,174 |
0 |
- |
|
| COO |
Cooper Companies Inc |
Director |
• • – |
2017-11-15 |
4 |
OE |
$0.00 |
$0 |
I/I |
1,570 |
11,403 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2017-06-09 |
4 |
A |
$2.47 |
$150,001 |
D/D |
60,729 |
201,826 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
